MISSISSAUGA, ON, March 31, 2015 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) today announced that Shawn Patrick O'Brien, President and Chief Executive Officer, will participate at the Laurentian Bank Securities 2nd Annual Investor Conference in Montreal, Quebec. Mr O'Brien is scheduled to take part in a panel discussion on Thursday, April 9, 2015 at 1:35 PM ET.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (NASDAQ: CPHR; TSX:CPH) is a growing specialty pharmaceutical company focused on dermatology. Cipher acquires products that fulfill high unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Cipher's key product, a novel version of the acne medication isotretinoin, is marketed as Absorica™ in the U.S. and Epuris® in Canada. Since the Company was founded in 2000, Cipher has achieved regulatory marketing approval in the U.S. and Canada for all three original products and completed eight marketing partnerships, generating growing revenue streams and shareholder value. Cipher is building its dermatology franchise through product licensing and acquisitions.
SOURCE Cipher Pharmaceuticals Inc.
For further information: Investors: In Canada: Lawrence Chamberlain, TMX Equicom, (416) 815-0700 ext 257, firstname.lastname@example.org; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, email@example.com; Media: Mike Beyer, Sam Brown Inc., Office: (773) 463-4211, Mobile: (312) 961-2502, firstname.lastname@example.org